Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Tatiana, Koudriavtseva"'
Autor:
Tatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, Mauro Truglio, Marco Fiorelli, Caterina Lapucci, Giovanna D’Agosto, Laura Conti, Annunziata Stefanile, Silvana Zannino, Maria Maddalena Filippi, Antonio Cortese, Carlo Piantadosi, Marta Maschio, Andrea Maialetti, Edvina Galiè, Marco Salvetti, Matilde Inglese
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectivesRecent studies supported coagulation involvement in multiple sclerosis, an inflammatory-demyelinating and degenerative disease of the central nervous system. The main objectives of this observational study were to identify the most specific
Externí odkaz:
https://doaj.org/article/42650cb519e44505ae0b4cc57d090de5
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 21, Pp 906-920 (2022)
Coronavirus disease 2019 (COVID-19) results in higher risks of hospitalization or death in older patients and those with multiple comorbidities, including malignancies. Patients with cancer have greater risks of COVID-19 onset and worse prognosis. Th
Externí odkaz:
https://doaj.org/article/fc31890324c3470ea88d77061f3438c4
Autor:
Marta Maschio, Andrea Maialetti, Diana Giannarelli, Tatiana Koudriavtseva, Edvina Galiè, Alessandra Fabi
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionRetrospective observational study on medical records of patients with epilepsy related brain metastases (BM) to evaluate efficacy, safety and possible interaction with cancer treatment of different anti-seizure medications (ASMs) and the
Externí odkaz:
https://doaj.org/article/23bc13ec823846d49bcd3663c37c4f9b
Autor:
Marta Maschio MD, Andrea Maialetti PsyD, Francesco Marchesi MD, Svitlana Gumenyuk MD, Francesco Pisani MD, Elena Papa MD, Edvina Galiè MD, Tatiana Koudriavtseva MD, Giuliana Graziano NFPT, Diana Giannarelli MD, Andrea Mengarelli MD
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Introduction: This is a phase II pilot study to evaluate the efficacy of a nutraceutical compound composed of nervonic acid, curcuma rizoma, and l-Arginine to prevent the onset of bortezomib-induced peripheral neuropathy (BIPN) in 16 newly diagnosed
Externí odkaz:
https://doaj.org/article/40c275cb06ae42ab88cb938b9ef8cb54
Homocysteine and Inflammatory Cytokines in the Clinical Assessment of Infection in Venous Leg Ulcers
Autor:
Ilaria Cavallo, Ilaria Lesnoni La Parola, Francesca Sivori, Luigi Toma, Tatiana Koudriavtseva, Isabella Sperduti, Daniela Kovacs, Giovanna D’Agosto, Elisabetta Trento, Norma Cameli, Anna Mussi, Alessandra Latini, Aldo Morrone, Fulvia Pimpinelli, Enea Gino Di Domenico
Publikováno v:
Antibiotics, Vol 11, Iss 9, p 1268 (2022)
Inflammation and biofilm-associated infection are common in chronic venous leg ulcers (VU), causing deep pain and delayed healing. Albeit important, clinical markers and laboratory parameters for identifying and monitoring persistent VU infections ar
Externí odkaz:
https://doaj.org/article/fdd6df5537d54ea1ad69b1eff24a05b4
Autor:
Tatiana Koudriavtseva, Svetlana Lorenzano, Vincenzo Anelli, Domenico Sergi, Annunziata Stefanile, Enea Gino Di Domenico, Marta Maschio, Edvina Galiè, Carlo Piantadosi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, promoting vasculogenesis. Bevacizumab inhibits cancer angiogene
Externí odkaz:
https://doaj.org/article/08d6b5d002714ea6a00b1e33186ad976
Autor:
Enea Gino Di Domenico, Ilaria Cavallo, Francesca Sivori, Francesco Marchesi, Grazia Prignano, Fulvia Pimpinelli, Isabella Sperduti, Lorella Pelagalli, Fabiola Di Salvo, Ilaria Celesti, Silvia Paluzzi, Carmelina Pronesti, Tatiana Koudriavtseva, Fiorentina Ascenzioni, Luigi Toma, Assunta De Luca, Andrea Mengarelli, Fabrizio Ensoli
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a prominent cause of nosocomial infections associated with high rates of morbidity and mortality, particularly in oncological patients. The hypermucoviscous (HMV) phenotype and biofilm production a
Externí odkaz:
https://doaj.org/article/3ad901e8741644e8a2ff019a3402c742
Autor:
Tatiana Koudriavtseva, Annunziata Stefanile, Marco Fiorelli, Caterina Lapucci, Svetlana Lorenzano, Silvana Zannino, Laura Conti, Giovanna D’Agosto, Fulvia Pimpinelli, Enea Gino Di Domenico, Chiara Mandoj, Diana Giannarelli, Sara Donzelli, Giovanni Blandino, Marco Salvetti, Matilde Inglese
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
IntroductionMultiple sclerosis (MS) is a demyelinating disease of the central nervous system with an underlying immune-mediated and inflammatory pathogenesis. Innate immunity, in addition to the adaptive immune system, plays a relevant role in MS pat
Externí odkaz:
https://doaj.org/article/19907d35133a4a73b2e188f86996faf9
Autor:
Marta Maschio, Alessia Zarabla, Andrea Maialetti, Diana Giannarelli, Tatiana Koudriavtseva, Veronica Villani, Silvana Zannino
Publikováno v:
Brain and Behavior, Vol 10, Iss 6, Pp n/a-n/a (2020)
Abstract Objective Possible loss of efficacy and potential interactions between antiepileptic drugs (AEDs) and chemotherapy could complicate the management of patients with brain tumor‐related epilepsy (BTRE) that may expose patients to an increase
Externí odkaz:
https://doaj.org/article/b6264a4ad7af4cf49a49d8b17ffd3054
Autor:
Antonietta Coppola, Alessia Zarabla, Andrea Maialetti, Veronica Villani, Tatiana Koudriavtseva, Emilio Russo, Agostino Nozzolillo, Chiara Sueri, Vincenzo Belcastro, Simona Balestrini, Edoardo Ferlazzo, Diana Giannarelli, Leonilda Bilo, Marta Maschio
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Epilepsy is one of the most common symptoms of brain tumors. It is often drug resistant and generally worsen patients' quality of life (QoL). Brain tumors release glutamate among other mediators, contributing to seizures onset, and this i
Externí odkaz:
https://doaj.org/article/45b4c1691c2544c5b1d49ef772fe39f6